Calgary, Alberta–(Newsfile Corp. – August 30, 2021) – EnerSpar Corp. (TSXV: ENER) (FSE: 5E0) (“EnerSpar” or the “Company“) and Nurexone Biologic Ltd. (“Nurexone“) are pleased to announce that they have entered an arms-length letter of intent dated 23 August 2021 (amended) pursuant to which EnerSpar and Nurexone propose to complete
Prof. Michael Belkin, Emeritus professor of Ophthalmology in Tel Aviv University, was the founder and the first director of the university’s Eye Research Institute at the Sheba Medical Center and is a senior advisor to the Singapore Eye Research Institute. He has authored over 250 scientific publications and over 35
Prof. Zeilig has served as director of the Department of Neurological Rehabilitation and the National Spinal Cord Injury Rehabilitation Unit at Sheba Medical Center, Tel Hashomer, Israel since 1999. He carried out a fellowship in Critical Care Neurotrauma and Neurorehabilitation fellowship at the University of Maryland Medical Center, Baltimore, MD
